PT80131B - Processo para a preparacao de composicoes farmaceuticas em forma de dosagem liquida apropriada para administracao de 4'-demetilepipodofilotoxina-9-{4,6-o(r)-etilideno-beta-d-glucopiranosido}(etoposido) por via oral - Google Patents

Processo para a preparacao de composicoes farmaceuticas em forma de dosagem liquida apropriada para administracao de 4'-demetilepipodofilotoxina-9-{4,6-o(r)-etilideno-beta-d-glucopiranosido}(etoposido) por via oral Download PDF

Info

Publication number
PT80131B
PT80131B PT80131A PT8013185A PT80131B PT 80131 B PT80131 B PT 80131B PT 80131 A PT80131 A PT 80131A PT 8013185 A PT8013185 A PT 8013185A PT 80131 B PT80131 B PT 80131B
Authority
PT
Portugal
Prior art keywords
etoposide
acid
weight
process according
polyethylene glycol
Prior art date
Application number
PT80131A
Other languages
English (en)
Portuguese (pt)
Other versions
PT80131A (en
Inventor
Ismat Ullah
Selima Begum
Bernard C Nunning
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of PT80131A publication Critical patent/PT80131A/pt
Publication of PT80131B publication Critical patent/PT80131B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT80131A 1984-03-19 1985-03-18 Processo para a preparacao de composicoes farmaceuticas em forma de dosagem liquida apropriada para administracao de 4'-demetilepipodofilotoxina-9-{4,6-o(r)-etilideno-beta-d-glucopiranosido}(etoposido) por via oral PT80131B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19

Publications (2)

Publication Number Publication Date
PT80131A PT80131A (en) 1985-04-01
PT80131B true PT80131B (pt) 1987-10-20

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80131A PT80131B (pt) 1984-03-19 1985-03-18 Processo para a preparacao de composicoes farmaceuticas em forma de dosagem liquida apropriada para administracao de 4'-demetilepipodofilotoxina-9-{4,6-o(r)-etilideno-beta-d-glucopiranosido}(etoposido) por via oral

Country Status (28)

Country Link
JP (1) JPS60209516A (no)
KR (1) KR850006136A (no)
AT (1) AT392904B (no)
AU (1) AU571308B2 (no)
BE (1) BE901963A (no)
CA (1) CA1238578A (no)
CH (1) CH662731A5 (no)
DE (1) DE3509741A1 (no)
DK (1) DK164535C (no)
EG (1) EG17521A (no)
ES (1) ES8702140A1 (no)
FI (1) FI84023C (no)
FR (1) FR2561104B1 (no)
GB (1) GB2155789B (no)
GR (1) GR850688B (no)
IE (1) IE58340B1 (no)
IL (1) IL74615A (no)
IT (1) IT1187640B (no)
LU (1) LU85812A1 (no)
MY (1) MY101916A (no)
NL (1) NL8500739A (no)
NO (1) NO170569C (no)
NZ (1) NZ211078A (no)
OA (1) OA07968A (no)
PT (1) PT80131B (no)
SE (1) SE8501312L (no)
YU (1) YU45243B (no)
ZA (1) ZA851935B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (no) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (de) * 1974-11-07 1976-05-13 Universal Oil Prod Co Verfahren zum betrieb einer verbrennungsmaschine
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
FR2410504A1 (fr) * 1977-12-05 1979-06-29 Air Liquide Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede
DE2809543A1 (de) * 1978-03-06 1979-09-13 Werner Henke Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤

Also Published As

Publication number Publication date
IL74615A (en) 1988-07-31
BE901963A (fr) 1985-09-18
EG17521A (en) 1990-06-30
ATA81985A (de) 1990-12-15
PT80131A (en) 1985-04-01
NO851022L (no) 1985-09-20
FI851040L (fi) 1985-09-20
IT1187640B (it) 1987-12-23
AU571308B2 (en) 1988-04-14
DE3509741A1 (de) 1985-09-26
MY101916A (en) 1992-02-15
FI84023C (fi) 1991-10-10
KR850006136A (ko) 1985-10-02
CH662731A5 (de) 1987-10-30
IL74615A0 (en) 1985-06-30
AT392904B (de) 1991-07-10
DK164535B (da) 1992-07-13
YU45243B (en) 1992-05-28
ES8702140A1 (es) 1986-12-16
FI84023B (fi) 1991-06-28
FI851040A0 (fi) 1985-03-15
NO170569B (no) 1992-07-27
NZ211078A (en) 1987-08-31
DK164535C (da) 1992-11-30
FR2561104B1 (fr) 1988-04-08
FR2561104A1 (fr) 1985-09-20
IE850686L (en) 1985-09-19
DK122285D0 (da) 1985-03-18
IE58340B1 (en) 1993-09-08
JPS60209516A (ja) 1985-10-22
GB2155789A (en) 1985-10-02
ES541370A0 (es) 1986-12-16
NO170569C (no) 1992-11-04
DK122285A (da) 1985-09-20
AU3897585A (en) 1985-09-26
GB8506943D0 (en) 1985-04-24
YU42085A (en) 1988-02-29
IT8519897A0 (it) 1985-03-14
GR850688B (no) 1985-07-08
NL8500739A (nl) 1985-10-16
GB2155789B (en) 1987-10-21
SE8501312D0 (sv) 1985-03-18
ZA851935B (en) 1985-10-30
CA1238578A (en) 1988-06-28
SE8501312L (sv) 1985-09-20
OA07968A (fr) 1987-01-31
LU85812A1 (fr) 1985-12-12

Similar Documents

Publication Publication Date Title
US4713246A (en) Etoposide oral dosage form
US5505961A (en) Gelatin capsules containing a highly concentrated acetaminophen solution
IE45288B1 (en) Improvements in or relating to pharmaceutical compostions for x-ray visualisation of the alimentary canal, and processes for preparing such compositions
PT1365749E (pt) Processo para preparar composições farmacêuticas para utilização com formulações de gelatina mole
US4927638A (en) Etoposide solutions
CZ289386B6 (cs) Farmaceutická kompozice
JPS62103020A (ja) 難溶性薬物の可溶化組成物
JP2009256216A (ja) 溶液状態で安定なアムロジピンベシル酸塩内服用液剤
PT80131B (pt) Processo para a preparacao de composicoes farmaceuticas em forma de dosagem liquida apropriada para administracao de 4'-demetilepipodofilotoxina-9-{4,6-o(r)-etilideno-beta-d-glucopiranosido}(etoposido) por via oral
US4880835A (en) Oral liquid pharmaceutical compositions of sulindac
US4772589A (en) Etoposide solution in NMP
ES2894115T3 (es) Composición para suplementación de calcio
KR900000513B1 (ko) 에토포사이드 경구 투여용 조성물의 제조방법
KR20190087039A (ko) 리세드론산 또는 그의 염 및 비타민d를 함유하는 경구용 에멀젼 조성물 및 그 제조방법
ES2905770T3 (es) Composición para la suplementación con calcio
US20230082870A1 (en) Composition for calcium supplementation
EA042006B1 (ru) Композиция в качестве добавки кальция
TW200302721A (en) Zoniporide mesylate pharmaceutical compositions and process for improving solubility of zoniporide

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940930